ZA834498B - Combination of beta-adrenoceptor antagonists and anxiolytic agents - Google Patents

Combination of beta-adrenoceptor antagonists and anxiolytic agents

Info

Publication number
ZA834498B
ZA834498B ZA834498A ZA834498A ZA834498B ZA 834498 B ZA834498 B ZA 834498B ZA 834498 A ZA834498 A ZA 834498A ZA 834498 A ZA834498 A ZA 834498A ZA 834498 B ZA834498 B ZA 834498B
Authority
ZA
South Africa
Prior art keywords
beta
combination
adrenoceptor antagonists
anxiolytic agents
anxiolytic
Prior art date
Application number
ZA834498A
Other languages
English (en)
Inventor
Katherine Voith
Original Assignee
Ayerst Mckenna & Harrison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna & Harrison filed Critical Ayerst Mckenna & Harrison
Publication of ZA834498B publication Critical patent/ZA834498B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA834498A 1982-06-25 1983-06-20 Combination of beta-adrenoceptor antagonists and anxiolytic agents ZA834498B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/392,417 US4468391A (en) 1982-06-25 1982-06-25 Combination of β-adrenoceptor antagonists and anxiolytic agents

Publications (1)

Publication Number Publication Date
ZA834498B true ZA834498B (en) 1985-02-27

Family

ID=23550497

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA834498A ZA834498B (en) 1982-06-25 1983-06-20 Combination of beta-adrenoceptor antagonists and anxiolytic agents

Country Status (10)

Country Link
US (1) US4468391A (xx)
EP (1) EP0098113B1 (xx)
JP (1) JPS5916827A (xx)
AT (1) ATE21822T1 (xx)
AU (1) AU556173B2 (xx)
CA (1) CA1200206A (xx)
DE (1) DE3365860D1 (xx)
GR (1) GR77542B (xx)
PH (1) PH19862A (xx)
ZA (1) ZA834498B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216555B1 (en) * 1985-09-11 1992-09-02 Btg International Limited Use of dioxopiperidine derivatives in the treatment of anxiety, for the reduction of chronic abnormally high brain levels of serotonin or 5-hydroxy-indoleacetic acid, and in the treatment of bacterial or viral infections
US5096586A (en) * 1990-08-28 1992-03-17 Regents Of The University Of California Membranes having selective permeability
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
JPH06190340A (ja) * 1992-09-11 1994-07-12 Sekisui Jushi Co Ltd 塗装金属体
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
CA2167526A1 (en) * 1993-09-29 1995-04-06 Lina Tormen Taskovich Monoglyceride/lactate ester permeation enhancer
US5484794A (en) * 1994-11-09 1996-01-16 Eli Lilly And Company Method for treating anxiety
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
AUPO274596A0 (en) * 1996-10-04 1996-10-31 Armstrong, Stuart Maxwell Method for the treatment of neurological or neuropsychiatric disorders
FR2834854B1 (fr) 2002-01-11 2004-05-28 Thales Sa Procede et systeme de decodage de tatouage

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1919342A1 (de) * 1969-04-16 1970-12-03 Boehringer Sohn Ingelheim Herzwirksame Kombinationspraeparate
DE2106071A1 (de) * 1970-02-17 1971-10-07 CIBA Geigy AG, Basel (Schweiz) Neue pharmazeutische Präparate
AT303707B (de) * 1970-02-17 1972-12-11 Ciba Geigy Ag Verfahren zur Herstellung von neuen 1-sek.Amino-2-hydroxy-3-[(p-alkenyloxy- oder p-alkinyloxy)-phenoxy]-propanen und ihren Säureadditionssalzen
US3959486A (en) * 1970-05-27 1976-05-25 Imperial Chemical Industries Limited Method for producing β-adrenergic blockage with alkanolamine derivatives
US4059622A (en) * 1970-05-27 1977-11-22 Imperial Chemical Industries Limited Alkanolamine derivatives
LU76150A1 (xx) * 1976-11-08 1978-07-10
DE2752384A1 (de) * 1977-08-29 1979-03-15 Simes Pharmazeutisches praeparat auf der basis beklemmungsloesender mittel und hemmstoffe der beta-adrenergischen rezeptoren
DE2926653A1 (de) * 1979-07-02 1981-01-22 Sandoz Ag Neue therapeutische verwendung von organischen verbindungen

Also Published As

Publication number Publication date
GR77542B (xx) 1984-09-24
CA1200206A (en) 1986-02-04
EP0098113A1 (en) 1984-01-11
AU1599283A (en) 1984-01-05
AU556173B2 (en) 1986-10-23
DE3365860D1 (en) 1986-10-09
EP0098113B1 (en) 1986-09-03
JPS5916827A (ja) 1984-01-28
PH19862A (en) 1986-08-13
ATE21822T1 (de) 1986-09-15
US4468391A (en) 1984-08-28

Similar Documents

Publication Publication Date Title
DE3365860D1 (en) A combination of beta-adrenoceptor antagonists and anxiolytic agents
DE3372173D1 (en) Process for coating galenics with a water-dispersed coating composition
AR002705A1 (es) Un nuevo compuesto de indolina, un proceso para su preparacion y composiciones farmaceuticas que lo contienen.
ES503882A0 (es) Dispositivo para el mezclado y desgasificacion de componen- tes de resinas sinteticas,especialmente de resinas artifia- les duroplasticas
MA19951A1 (fr) Procede de preparation d'acides amines tricycliques ainsi que des acides amines bicycliques servant d'intermediaires et leur utilisation comme medicament
LV11894B (en) Jauni hromána un tiohromána atvasinájumi
IT8619917A0 (it) Metodo ed apparato per la polverizzazione di combustibile.
ES2161718T3 (es) 2,5-dioxo-2,5-dihidro-1h-benzo(b)azepinas como antagonistas de los receptores de nmda.
YU10579A (en) Process for obtaining new derivatives of substituted benzamides
EP0082364A3 (en) (+)-2-(1-(2,6-dichlorophenoxy)-ethyl)-1,3-diazacyclopent-2-ene, process for its preparation and its use in pharmaceutical compositions
DE3571933D1 (en) Apparatus for the administration of liquids by means of an injector
ES550774A0 (es) Un procedimiento para preparar pirazol (3,4,5-kl)acridinas
ZA843489B (en) 4-oxothiazolidin-2-ylidene-acetamide derivatives,processes for their preparation and their use in the combating of diseases of the central nervous system
TW221439B (xx)
DE3373827D1 (en) Process for the hydrogenation of heavy oils, bitumen and the like
ES541944A0 (es) Procedimiento para preparar liposomas que contiene alergenoso fracciones de alergenos inhalables
IT1173444B (it) Procedimento per la decontaminazione esauriente degli olii perfluoropolieteri
AR010304A1 (es) Compuestos de dimesilato de cis-1-(3-etoxifenil)-1-4-fenilpiperazin-1-il) -4-metilciclohexano; procedimiento para su preparacion y composicionfarmaceutica
Imes Cognitive rehabilitation of brain-damaged patients: An annotated bibliography.
JPS57179412A (en) Preventive device for relaxation of rail connecting bolt
PL131810B2 (en) Method of manufacture of colouring agents for cellulosicfibres,polyamide and paper for imparting them brown and red colours
PH19278A (en) Pharmaceutical composition comprising(1,2,4,)triazolo(4,3a)quinoxaline 4 amine derivatives as anti tumor and anti fatigue agents